BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2760512)

  • 1. Effects of synthetic human gastrin-releasing peptide on pancreatic exocrine secretion and release of pancreatic polypeptide in conscious rats.
    Miyasaka K; Miyazaki K; Funakoshi A; Kitani K; Yajima H
    Int J Pancreatol; 1989 Apr; 4(3):251-60. PubMed ID: 2760512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
    Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of atropine on bombesin and gastrin releasing peptide stimulated gastrin, pancreatic polypeptide and neurotensin release in man.
    Fletcher DR; Shulkes A; Bladin PH; Hardy KJ
    Regul Pept; 1983 Sep; 7(1):31-40. PubMed ID: 6647889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of gastrin releasing peptide on exocrine pancreatic secretion and plasma levels of CCK and PP in conscious dogs].
    Hosotani R; Inoue K; Okuno T; Miyata S; Tobe T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Apr; 82(4):664-72. PubMed ID: 4021169
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of synthetic porcine gastrin-releasing peptide on plasma levels of immunoreactive cholecystokinin pancreatic polypeptide and gastrin in dogs.
    Inoue K; McKay D; Yajima H; Rayford PL
    Peptides; 1983; 4(2):153-7. PubMed ID: 6622284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin.
    Masuda M; Tomita H; Okubo K; Miyasaka K
    J Auton Nerv Syst; 1994 Dec; 50(2):131-8. PubMed ID: 7884153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of unstimulated exocrine pancreatic secretion by peptide YY in the rat.
    Robinson DC; Rudnicki M; Tito JM; Gold MS
    World J Surg; 1996 Feb; 20(2):208-14. PubMed ID: 8661819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
    Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gastrointestinal peptides on pancreatic secretion in response to different stimulants in conscious rats.
    Ami M; Doi R; Inoue K; Chowdhury P; Rayford PL
    Int J Pancreatol; 1993 Dec; 14(3):245-52. PubMed ID: 8113626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R; Chowdhury P; Rayford PL
    Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polypeptide secretion from the isolated perfused ventral and dorsal areas of the rat pancreas.
    Miyazaki K; Funakoshi A
    Gastroenterology; 1988 Mar; 94(3):745-9. PubMed ID: 3338643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of pancreatic polypeptide (PP) in luminal feedback regulation in the conscious rat.
    Miyasaka K; Miyazaki K; Funakoshi A; Kitani K
    Dig Dis Sci; 1989 Mar; 34(3):474-80. PubMed ID: 2920653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H; Debas HT; Bunnett NW
    Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of divalent cations on gastrointestinal hormone release and exocrine pancreatic secretion in dogs.
    Inoue K; Fried GM; Wiener I; Sakamoto T; Lilja P; Greeley GH; Watson LC; Thompson JC
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G28-34. PubMed ID: 3966559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenteropancreatic effects of xenin in the dog.
    Feurle GE; Heger M; Niebergall-Roth E; Teyssen S; Fried M; Eberle C; Singer MV; Hamscher G
    J Pept Res; 1997 Apr; 49(4):324-30. PubMed ID: 9176815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of human pancreatic polypeptide on exocrine pancreatic function in conscious rats.
    Funakoshi A; Miyasaka K; Shinozaki H; Kitani K; Sugiyama N; Yajima H
    Tohoku J Exp Med; 1988 Jan; 154(1):1-9. PubMed ID: 3363559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of luteinizing hormone-releasing hormone on pancreatic exocrine secretion and release of gastrin and pancreatic polypeptide in dog.
    Becker S; Singer MV; Eysselein VE; Goebell H
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):138-45. PubMed ID: 7052004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin-releasing peptide: effect on exocrine secretion and release from isolated perfused porcine pancreas.
    Knuhtsen S; Holst JJ; Jensen SL; Knigge U; Nielsen OV
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G281-6. PubMed ID: 3976887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of canine pancreatic polypeptide, gastrin, and gastric acid secretion by ranatensin, litorin, bombesin nonapeptide and substance P.
    Modlin IM; Lamers CB; Walsh JH
    Regul Pept; 1981 Jan; 1(4):279-88. PubMed ID: 6166964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.